ANNOUNCEMENT 23 Aug 2016

The government-funded Company of Innovation and Research of Brazil (FINEP) approved a BRL 61 million to Diagnosticos da America S.A.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Projetos contratados e valores liberados. Retrieved on 02/05/2018. Available at: http://finep.gov.br/acesso-a-informacao-externo/transparencia/projetos-contratados-e-valores-liberados

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Financiamento Reembolsável. Available at: http://finep.gov.br/component/content/article/120-apoio-e-financiamento/tipos-de-apoio/financiamento-reembolsavel/42-financiamento-reembolsavel

Inception date: 23 Aug 2016 | Removal date: 23 Aug 2018
Still in force

State loan

On 23 August 2016, the Brazilian Company of Innovation and Research (FINEP) announced the approval of BRL 61 million (USD 19 million) loan allocated to the local medical diagnostics company Diagnosticos da America S.A. The objective of these resources is to finance a project that focuses on developing innovative exams and services in Onco-Hematology, advanced imaging diagnosis of Cancer, microbiology, and CRM.

The repayment deadline for the credit has been set to 23 August 2018.


FINEP lending
The resources enclosed on the programs managed by FINEP are limited to Brazilian companies and seek to boost the national and international competitiveness of these businesses.

The interest rates set on the credit lines are composed of the long-term interest rate (TJLP) plus a supplement ranging between 1.5% and 7%, depending on the credit line and the repayment period.

AFFECTED SECTORS

 

AFFECTED PRODUCTS

 
N/A